Vertebral bone mineral density got a boost from new SERM.(Rx)

Publication: Internal Medicine News

Publication Date: 15-DEC-04

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2004 International Medical News Group

SAN ANTONIO -- The next generation selective-estrogen receptor modulator, lasofoxifene, increased vertebral bone mineral density better than did raloxifene, according to the findings of a company-sponsored trial presented at the annual meeting of the American College of Rheumatology.

In the study, 410 postmenopausal women were randomly assigned to one of...

Read the full article for free courtesy of your local library.